Artemisinin Protocol
Uses artemisinin, extracted from sweet wormwood (artemisia annua), for powerful antiparasitic action, especially against malaria, with emerging evidence for antimicrobial, antiviral, and anticancer effects.
Overview
Artemisinin is a natural compound extracted from sweet wormwood (Artemisia annua), discovered in 1972 by Tu Youyou who won the 2015 Nobel Prize for this groundbreaking work. Medical consensus considers artemisinin-based combination treatments as the go-to therapy for malaria worldwide. Artemisinin creates powerful free radicals when it encounters iron, which is found in high concentrations inside parasites and some cancer cells, essentially destroying them from within. Modern artemisinin combinations have success rates above 95% against malaria. Beyond malaria treatment, research shows artemisinin can fight other parasites too, including Toxoplasma gondii (which causes toxoplasmosis) and Babesia species (tick-borne parasites) in laboratory studies. Recent research shows promise against other parasitic infections like schistosomiasis and even potential applications in cancer research.
Key Benefits
First-line treatment worldwide for malaria with over 130 years of medical research heritage. Shows promise against other parasitic infections including Babesia and Toxoplasma in laboratory studies. Demonstrates broad antimicrobial activity against bacteria, fungi, and certain parasites with documented safety profile in clinical trials. May offer therapeutic potential in cancer research and chronic inflammatory conditions under medical supervision. Use pharmaceutical-grade artemisinin derivatives at precisely calculated doses with proper cycling protocols to maximise antiparasitic benefits while minimising potential side effects.